Corticosteroids Market Report 2026

Corticosteroids Market Overview

• Corticosteroids market size has reached to $5.93 billion in 2025 • Expected to grow to $8.34 billion in 2030 at a compound annual growth rate (CAGR) of 7.1% • Growth Driver: Rising Demand For Cancer Treatment Drives Market Growth • Market Trend: Innovative Rescue Medication Developments In The Corticosteroids Market • North America was the largest region in 2025 and Middle East is the fastest growing region.

What Is Covered Under Corticosteroids Market?

Corticosteroids therapy refers to a treatment that is given in a variety of ways to stifle the immune system and reduce inflammation. Asthma is one of the disorders they are used to treat allergy symptoms such as hay fever, and urticaria (hives). Corticosteroids, sometimes known as steroids, are a kind of anti-inflammatory medication. The main product types of corticosteroids therapy are glucocorticoids and mineralocorticoids. Glucocorticoids are a type of corticosteroid hormone that is very effective at suppressing the immune system and reducing inflammation. The therapy is used for the treatment of skin allergies, rheumatology indications, endocrinology, acute respiratory diseases by hospitals, clinics, research institutes, and others.

What Is The Corticosteroids Market Growth Forecast?

The corticosteroids market size is expected to see strong growth in the next few years. It will grow to $8.34 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to growing autoimmune and respiratory disease burden, development of safer steroid formulations, aging global population, rising healthcare access in emerging economies, increased investment in corticosteroid research. Major trends in the forecast period include targeted corticosteroid formulations, low dose and short duration therapies, growth of topical and inhaled corticosteroids, combination therapies with bronchodilators, expanding use in acute respiratory care.

What Is The Driver Of The Corticosteroids Market?

The rising demand for cancer treatment will propel the growth of the corticosteroid market going forward. Cancer treatment encompasses various therapies, such as surgery, chemotherapy, radiation therapy, immunotherapy, and targeted treatments, designed to eradicate cancer cells and alleviate symptoms. The rising demand for cancer treatment is driven by several factors, including increasing cancer incidence, greater awareness and screening, improved access to healthcare, and the availability of supportive care services. By alleviating symptoms and enhancing the tolerability of cancer treatments, corticosteroids lead to improved patient outcomes, thereby supporting the increasing demand for comprehensive cancer care. For instance, in May 2024, the National Health Service (NHS), the UK’s healthcare system, reported that treatment activity reached its highest level of all time, with over 1,400 patients initiating cancer treatment each working day. Between April 2023 and March 2024, nearly 340,000 individuals received their first cancer treatment. Therefore, rising demand for cancer treatment drives the growth of the corticosteroid industry.

Key Players In The Global Corticosteroids Market

Major companies operating in the corticosteroids market are McKesson Corporation, Pfizer Inc., Johnson and Johnson Services Inc., Merck & Co.Inc., Bayer AG, Novartis International AG., Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy's Laboratories Ltd., Endo International plc, Lupin Limited, Mallinckrodt Pharmaceuticals Ltd., LEO Pharma A/S, Glenmark Pharmaceuticals Ltd., Wockhardt Limited, Allergan plc, Hikma Pharmaceuticals pl.

Global Corticosteroids Market Trends and Insights

Major companies operating in the corticosteroids market are developing innovative products such as rescue medications to meet larger customer bases, more sales, and increase revenue. Rescue medication refers to a type of medication or treatment that is used to provide quick and immediate relief from acute and severe symptoms of a medical condition or a sudden exacerbation of a chronic condition. For instance, in January 2023, AstraZeneca PLC, a UK-based pharmaceutical company, announced the FDA approval for the Airsupra (albuterol/budesonide). One distinctive characteristic of this product is that it is the first-in-class pressurized metered-dose inhaler (pMDI), which is a fixed-dose combination rescue medication. It contains albuterol, a short-acting beta2-agonist (SABA), and budesonide, an inhaled corticosteroid (ICS) with anti-inflammatory properties. This product is indicated for individuals aged 18 years and older and can be utilized on an as-needed basis for the treatment or prevention of bronchoconstriction. It also helps in lowering the risk of asthma exacerbations. This combination is available in the United States and is under development by AstraZeneca in collaboration with Avillion.

What Are Latest Mergers And Acquisitions In The Corticosteroids Market?

In June 2024, Sun Pharmaceutical Industries Ltd., an India-based specialty generic pharmaceutical company, acquired Taro Pharmaceutical Industries Ltd. for an undisclosed amount. The aim of the acquisition is to strengthen Sun Pharma's position in the pharmaceutical market, particularly in areas such as off-patent pharmaceuticals, prescriptions, and over-the-counter products. Taro Pharmaceutical Industries Ltd is an Israel-based research-based pharmaceutical manufacturer including corticosteroids.

What Defines the Corticosteroids Market?

The corticosteroids therapy market consists of sales of glucocorticoids, mineralocorticoids, cortisone, hydrocortisone, and prednisone. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Corticosteroids Market Report 2026?

The corticosteroids market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the corticosteroids industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.